NLM Digital Collections

Search

Start Over Authors Chapman, Rick M., author ✖Remove constraint Authors: Chapman, Rick M., author Publication Year 2021 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2021">2021</span>

1. Supervised injection facilities and other supervised consumption sites: effectiveness and value : final report

Author(s):
Armbrecht, Eric, author
Guzauskas, Greg, author
Hansen, Ryan, author
Pandey, Rajshree, author
Fazioli, Katherine, author
Chapman, Rick M., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 8, 2021
Subject(s):
Harm Reduction
Needle-Exchange Programs
Opiate Overdose -- prevention & control
Opioid-Related Disorders -- therapy
United States

2. Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value : final report

Author(s):
Atlas, Steven J., author
Touchette, Daniel R., author
Beinfeld, Molly, author
McKenna, Avery, author
Joshi, Mrinmayee, author
Chapman, Rick M., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 15, 2021
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Urinary Bladder Neoplasms -- drug therapy
Genetic Vectors -- therapeutic use
United States